Accessibility: Skip TopNav
Discovery of Ruxoprubart (NM8074)
Ruxoprubart was selected as a lead candidate for the treatment of Dermatomyositis (DM)
Format
JPEG
Source
NovelMed Therapeutics Inc
Downloads
Original
Large
Medium
Small